AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36

Authors: Ben Halima, M Pasquier, C Slim, A Ben Chaabane, T Arrouji, Z Puel, J Ben Redjeb, S Izopet, J
Citation: M. Ben Halima et al., First molecular characterization of HIV-1 Tunisian strains, J ACQ IMM D, 28(1), 2001, pp. 94-96

Authors: Sandres, K Dubois, M Pasquier, C Puel, J Izopet, J
Citation: K. Sandres et al., Determination of HCV genotype using two antibody assays and genome typing, EUR J CL M, 20(9), 2001, pp. 666-669

Authors: Caillaud, D Galinier, M Elbaz, M Carrie, D Puel, J Fauvel, JM Arnal, JF
Citation: D. Caillaud et al., Role of nitric oxide in atherosclerosis, PRESSE MED, 30(1), 2001, pp. 41-44

Authors: Ducimetiere, P Signeyrole, D Giral, P Hoog-Labouret, N Amarenco, P Chanu, B Chauvenet, M Coletti, M Dallongeville, J Durlach, V Kawka, G Krempf, M Leroux, G Mlika-Cabanne, N Monnier, L Paillard, F Rostoker, G Sicard, D Verny, C Voiriot, P Acquart, B Alquier, G Ankri, J Badoc, G Basdevant, A Belmin, J Berthezene, F Beucler, I Blanc, F Broustet, JP Bruckert, E Brun, JM Castaigne, A Charpentier, JM Andre, MC Cogneau, J Demeaux, JL Denolle, T Desson, JF Drahi, E Drouin, P Dumel, F Emmerich, J Farnier, M Fontbonne, A Forette, B Gambert, P Gautier, JC Guillausseau, PJ Hommel, M Janowski, M Le Goaziou, MF Lievre, M Le Quere, M Leys, D Marechaud, R Mas, JL Menard, J Michel, JM Mounier-Vehier, F Mottier, D Passa, P Pinel, JF Puel, J Raccah, D Renou, P Ribier, A Schlienger, JL Thomas, D Vallee, JP Veyssier-Belot, C Bouvenot, G Abadie, E Alexandre, JM Belorgey-Bismut, C Bergmann, JF Camelli, B Caulin, C Costagliola, D Denis, C Dupuis, B Fleurette, F Guillevin, L Hoog-Labouret, N Paintaud, G Rauss, A Poynard, T Rostoker, G Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110

Authors: Foley, DP Pieper, M Wijns, W Suryapranata, H Grollier, G Legrand, V de Scheerder, I Hanet, C Puel, J Mudra, H Bonnier, HJRM Colombo, A Thomas, M Probst, P Morice, MC Kleijne, J Serruys, PW
Citation: Dp. Foley et al., The influence of stent length on clinical and angiographic outcome in patients undergoing elective stenting for native coronary artery lesions - Final results of the Magic 5L Study, EUR HEART J, 22(17), 2001, pp. 1585-1593

Authors: Bacquet, P Levy, E McGuire, A McMurray, J Merot, JL Paschen, B Remme, WJ Szucs, TD Klein, W Brunhuber, W Hofmann, R Kuhn, P Nesser, HJ Slany, J Weihs, W Wiedermann, C Wimmer, H van Mieghem, W Boland, J Chaudron, JM Jordaens, L Melchior, JP Aschermann, M Bruthansl, J Hradec, M Kolbel, F Semrad, B Haghfelt, T Hansen, JF Goetzsche, CO Hildebrandt, P Kassis, E Rasmussen, V Rokkedal, J Thomassen, A Groundstroem, K Uusimaa, P Le Heuzey, JY Aumont, MC Aupetit, JF Baille, N Baudouy, P Belin, A Bonneau, A Bonneric, G Bousser, JP Citron, B Dary, P Decoulx, E De Groote, P Denolle, T Dievart, F Duriez, P Eicher, JC Enjuto, G Ferriere, M Fournier, E Garandeau, M Gauthier, J Genest, M Gerbe, A Godenir, JP Guillot, B Guillot, JP Guillot, P Heno, P d'Ivernois, C Jean, M Kacet, S Kalle, R Komajda, M Lacroix, A Lallemand, R Lardoux, H Marquet, M Martin, M Martin, O Mery, D Mossaz, R Mothes, P Olive, T Ostorero, M Paganelli, F Page, E Pauly-Laubry, C Puel, J Rousseau, JF Roux, JJ Schenowitz, A Sourdais, K Tremel, F Verdun, A Witchiz, S Wolf, JE Hombach, V Assmann, I Beyer, T Bischoff, KO Darius, H Ertl, G Fleck, E Forster, K Freytag, F Gleichmann, U Haasis, R Henssge, R Hey, D Hesse, P Hofs, T Keck, M Klein, H Kromer, ET Kruls-Munch, J Luderitz, B Maisch, B Mitrovic, V Neubauer, S Osterziel, KJ Simon, H Spitzer, SG Stohring, R Taubert, G Teichmann, W Theisen, K Wende, W Wieser, H Zotz, R Bridges, A Adgey, J Ambepitiya, G Boon, N Boyle, RM Cowley, AJ Cripps, T Davies, MK Dunn, F Findlay, J Forsey, P Fyfe, T Gould, B Greenwood, TW Hubner, P Khan, S Lewis, P Mackay, A Maltz, M McArthur, J McLeod, A McLeod, D Metcalfe, M Millar-Craig, M Mills, P Nelson, JK Nicholls, D Oakley, GD Patterson, DLH Pohl, JEF Ray, S Silke, B Wilkinson, PR Preda, I Csanady, M Cserhalmi, L Edes, I Gesztesi, T Karpati, P Simon, K Tarjan, J Fogari, R Tramarin, R Galie, N Giani, P Milanese, U Scalvini, S Scrutinio, D Sechi, LA Tettamanti, F De Vito, F Crean, P McCann, H Mulcahy, D Sugrue, D van Hoogenhuyze, DCA van der Burgh, PH Ciampricotti, R van Dantzig, JM DenHartog, FR Henneman, JA van Kesteren, HAM Kragten, JA Liem, KL Limburg, A van der Linde, MR Linssen, GCM Pasteuning, H Penn, HJAM Van Rossum, P Schaafsma, HJ Schelling, A Sloos, R Wesdorp, JCL Korewicki, J Achremczyk, P Czestockowska, E Dowgird, M Dyduszynski, A Gorski, J Ilmurzynska, K Janicki, K Kornacewicz-Jach, Z Kraska, T Krzeminska-Pakula, M Kuch, J Nartowicz, E Petelenz, T Piwowarska, W Rawczynska-Englert, I Ruzyllo, W Swiatecka, G Tendera, M Wierzchowiecki, M Wodniecki, J Wojciechowoski, D Wrabec, K Wysocki, H Gomes, RS Ceia, MF Lousada, N Campos, JMM Providencia, LA de Moura, ALZC Marejev, VJ Aronov, DM Arutjunov, GP Bart, BJ Basechikin, SS Belenkov, JN Beloussov, JB Bokeria, OA Charchogljan, RA Doschytsin, V Fedorova, TA Glezer, MG Gorbachenkov, A",Gorshkov,"Gospodarenko, AL Ivashkin, VT Ivleva, AJ Kyrichenko, AA Lavrov, AA Lazebnik, LB Marynov, A Mazaev, VP Polejev, NR",Shpektor,"Sidorenko, BA Sobolev, KE Starodoubtsev, AK Storozhakhov, GI Syrkin, AL Zodionchenko, VS Zvereva, TV Murin, J Kaliska, G Rybar, R Valle, V Artaza, M Conthe, P Cruz, JM Garcia-Moll, M Lopez-Sendon, JL Martinez, A Monzon, F Ribas, M Roig, E Roldan, I Hoglund, C Ekdahl, S Hjelmaeus, L Lindberg, K Lofdahl, P Ulvenstam, G Warselius, L Follath, F Anghern, W Dubach, P Erne, P Gallino, A Moccetti, T Jmouro, AV Dargie, HJ Erdmann, E Follath, F Hoglund, C Lechat, P Sendon, JLL Mareyev, V Remme, WJ Sadowski, Z Seabra-Gomes, RJ Zannad, F Wehrlen-Grandjean, M Funck-Brentano, C Hansen, S Hohnloser, S Vanoli, E Jaillon, P De Baker, G Dahlstrom, U Hill, C Leizorovicz, A Burgnard, F Rolland, C Wiemann, H Verkenne, P Arab, T Cussac, N Dussous, V Haise, S Funck-Brentano, C
Citation: P. Bacquet et al., Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II), EUR HEART J, 22(12), 2001, pp. 1021-1031

Authors: Pasquier, C Millot, N Njouom, R Sandres, K Cazabat, M Puel, J Izopet, J
Citation: C. Pasquier et al., HIV-1 subtyping using phylogenetic analysis of pol gene sequences, J VIROL MET, 94(1-2), 2001, pp. 45-54

Authors: Koning, R Eltchaninoff, H Commeau, P Khalife, K Gilard, M Lipiecki, J Coste, P Bedossa, M Lefevre, T Brunel, P Morice, MC Maillard, L Guyon, P Puel, J Cribier, A
Citation: R. Koning et al., Stent placement compared with balloon angioplasty for small coronary arteries - In-hospital and 6-month clinical and angiographic results, CIRCULATION, 104(14), 2001, pp. 1604-1608

Authors: Puel, J
Citation: J. Puel, Small or big, ARCH MAL C, 94(7), 2001, pp. 649-650

Authors: Boveda, S Albenque, JP Baccar, H Galinier, M Donzeau, JP Salvador, M Bounhoure, JP Delay, M Puel, J Fauvel, JM
Citation: S. Boveda et al., Prophypactic value of the automatic implantable defibrillator: a case report of asymptomatic Brugada's syndrome., ARCH MAL C, 94(1), 2001, pp. 79-84

Authors: Puel, J
Citation: J. Puel, The best of coronary angioplasty in 2000 or already the post-interventional, ARCH MAL C, 94, 2001, pp. 65-68

Authors: Puel, J
Citation: J. Puel, Statins and unstable angina: MIRACL, ANN ENDOCR, 62(2), 2001, pp. 145-148

Authors: Carrie, D Khalife, K Citron, B Izaaz, K Hamon, M Juiliard, JM Leclercq, F Fourcade, J Lipiecki, J Sabatier, R Boulet, V Rinaldi, JP Mourali, J Sabatier, R Boulet, V Rinaldi, JP Mourali, S Fatouch, M El Mokhtar, E Aboujaoude, F Elbaz, M Grolleau, R Steg, PG Puel, J
Citation: D. Carrie et al., Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris, AM J CARD, 87(6), 2001, pp. 693-698

Authors: Pellegrin, I Segondy, M Garrigue, I Izopet, J Montes, B Pellegrin, JL Reynes, J Massip, P Puel, J Fleury, H
Citation: I. Pellegrin et al., Phenotypic resistance pattern of HIV-1 isolates with zidovudine and/or multidrug resistance mutations after didanosine-stavudine combination therapy, J ACQ IMM D, 25(5), 2000, pp. 465-466

Authors: Vermeer, F Vahanian, A Fels, PW Besse, P Muller, E Van de Werf, F Fitzgerald, D Darius, H Puel, J Garrigou, D Simoons, ML
Citation: F. Vermeer et al., Argatroban and alteplase in patients with acute myocardial infarction: TheARGAMI study, J THROMB TH, 10(3), 2000, pp. 233-240

Authors: Izopet, J Massip, P Souyris, C Sandres, K Puissant, B Obadia, M Pasquier, C Bonnet, E Marchou, B Puel, J
Citation: J. Izopet et al., Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen, AIDS, 14(15), 2000, pp. 2247-2255

Authors: Pasquier, C Daudin, M Righi, L Berges, L Thauvin, L Berrebi, A Massip, P Puel, J Bujan, L Izopet, J
Citation: C. Pasquier et al., Sperm washing and virus nucleic acid detection to reduce HIV and hepatitisC virus transmission in serodiscordant couples wishing to have children, AIDS, 14(14), 2000, pp. 2093-2099

Authors: Tamalet, C Pasquier, C Yahi, N Colson, P Poizot-Martin, I Lepeu, G Gallais, H Massip, P Puel, J Izopet, J
Citation: C. Tamalet et al., Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection, J MED VIROL, 61(2), 2000, pp. 181-186

Authors: Rostaing, L Izopet, J Sandres, K Cisterne, JM Puel, J Durand, D
Citation: L. Rostaing et al., Changes in hepatitis C virus RNA viremia concentrations int long-term renal transplant patients after introduction of mycophenolate mofetil, TRANSPLANT, 69(5), 2000, pp. 991-994

Authors: Sandres, K Dubois, M Pasquier, C Payen, JL Alric, L Duffaut, M Vinel, JP Pascal, JP Puel, J Izopet, J
Citation: K. Sandres et al., Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy, J VIROLOGY, 74(2), 2000, pp. 661-668

Authors: Izopet, J Rostaing, L Sandres, K Cisterne, JM Pasquier, C Rumeau, JL Duffaut, M Durand, D Puel, J
Citation: J. Izopet et al., Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients, J INFEC DIS, 181(3), 2000, pp. 852-858

Authors: Serruys, PW Foley, DP Hofling, B Puel, J Glogar, HD Seabra-Gomes, R Goicolea, J Coste, P Rutsch, W Katus, H Bonnier, H Wijns, W Betriu, A Hauf-Zachariou, U van Swijndregt, EM Melkert, R Simon, R
Citation: Pw. Serruys et al., Carvedilol for prevention of restenosis after directional coronary atherectomy - Final results of the European Carvedilol Atherectomy Restenosis (EUROCARE) trial, CIRCULATION, 101(13), 2000, pp. 1512-1518

Authors: Puel, J
Citation: J. Puel, Coronary recanalization: Republican plan and duty, ARCH MAL C, 93(4), 2000, pp. 345-346

Authors: Meyer, P Barragan, P Blanchard, D Chevalier, B Commeau, P Danchin, N Fajadet, J Grand, A Lablanche, JM Machecourt, J Metzger, JP Monassier, JP Neimann, JL Puel, J Steg, PG
Citation: P. Meyer et al., French Cardiac Society's recommendations, about angioplastic and coronarographic surgeons' professional training: Organization and equipement of coronarography and coronary angioplasty centers., ARCH MAL C, 93(2), 2000, pp. 147-158

Authors: Somody, E Albucher, JF Casteignau, G Prouteau, N Danielli, A Delay, M Chollet, F Puel, J
Citation: E. Somody et al., Anomalies of the interatrial septum and latent atrial vulnerability in unexplained ischaemic stroke of young adults., ARCH MAL C, 93(12), 2000, pp. 1495-1500
Risultati: 1-25 | 26-36